| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212939 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 33 Pages |
Abstract
The findings of this nationwide, multicenter, retrospective study demonstrate that HDR-BT as monotherapy was safe and effective for all patients with low-, intermediate-, and high-risk prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yasuo MD, Tadayuki MD, Akira MD, Shinji MD, Koji MD, Norio MD, Kazuhiko MD, Eiichi MD, Kensaku MD, Yasuyoshi MD, Hiroshi MD, Takuji MD, Ichiro MD, Kazuo MD, Teruki MD, Katsumasa MD, Jun MD,